Your Cart ( 1 Item )

• Hair Depigmentation During ChemotherapyWith Dasatinib, a Dual Bcr-Abl/Src FamilyTyrosine Kinase Inhibitor
  April 2009 | Volume 8 | Issue 4 | Case Reports | 395 | Copyright © April 2009
  Angel Sun, Russel S. Akin, Everado Cobos,Jennifer Smith MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs